King's College London

Research portal

Metabonomics: The future of personalized healthcare in liver intensive care?

Research output: Contribution to journalArticle

R. Zia, M. Coen, M. McPhail, I. Wilson

Original languageEnglish
Pages (from-to)2-5
Number of pages4
JournalThe Biochemist
Issue number1
Publication statusPublished - 1 Feb 2016

King's Authors


Metabonomics involves the use of high-resolution analytical platforms to characterize the low-molecular-mass metabolic composition of biofluids and tissues. The resulting complex metabolic phenotype data are modelled using multivariate statistical approaches to identify systems levels panels of metabolites that discriminate between phenotypes (metabotypes), providing mechanistic insight and candidate biomarkers. With the increasing incidence of liver cirrhosis nationally, the pressures on NHS liver units is set to intensify, with mortality rates in these patients remaining high. This article describes a personalized medicine approach to stratify patients' mortality risk using metabolic phenotyping. This could aid doctors in clinical decision-making for patient transplant candidacy and critical care management to improve current survival rates.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454